Introduction
Metabolism is a dedicated network of enzyme and metabolite-derived mechanisms that is a hallmark of life activities. A healthy metabolism is a basic necessity for a healthy life that depends on lifestyle, energy intake, and expenditure. A balanced lifestyle comprising healthy eating habits, exercise, sleep cycle, and behavioral features is the utmost regulator of healthy body weight and robust metabolism.
The present-day world is challenged by an increasing prevalence of overweight and obesity, amounting to epidemic proportions. This creates a public health concern and points to our lack of success in achieving healthy population indices in terms of healthy body weight maintenance.[1] Increased weight parallels with several comorbidities such as type-2 diabetes, some types of cancers, cardiovascular disorders, liver and kidney diseases, digestive problems, sleep apnea, osteoarthritis, etc.[2][3][4][5][6] Recent research indicates that the inability to maintain a healthy weight perturbs the body's metabolic and immunological axis, increasing the risk for severe illnesses such as COVID-19 and other infectious diseases.[1][7] Notably, absolute weight loss with long-term maintenance directly correlates with improvements in all health risk factors.[8]
Maintaining a healthy body weight, especially after weight reduction, requires equalized input and energy output to regulate optimal metabolism. This comprises a concerted regulation of enzyme activities, ATP synthesis, utilization, hormonal functions, neurological and muscular activities, etc. However, a general preference for high-tasting vis-à-vis less nutritious food and a sedentary lifestyle has led to a global increase in weight and also a reduced tendency of long-term maintenance of a healthy weight after effective weight loss.[9]
It is believed that weight loss at a slow rate is better sustained than weight loss more rapidly. However, scientific evidence shows that greater initial weight loss is positively related to long-term weight maintenance. This follows through a metabolic adaptation process, leading to healthier metabolic functions. Nonetheless, healthy weight maintenance achieved through weight loss regimens also requires care and treatment, usually through diet regimens or restrictions and exercise. However, no specific diet or exercise program has been established as a successful regimen for weight maintenance. Weight management strategies underline the significance of attaining a 5% weight loss to maintain a healthy metabolism.
Prior to understanding the consequences of weight loss on metabolism, it is imperative to recognize that at the metabolic level, weight loss is a continuous metabolic adaptation process progressing through many biochemical and physiological changes involving the role of hormones, enzyme functions, metabolite effectors, and bioenergetics.
Maintaining a healthy weight is challenging. It is shown that most individuals tend to have regained a significant amount of the lost weight within a year after weight loss. With this increased prevalence of recidivism, weight management is viewed as a chronic issue. Hence, long-term care is expected for weight management and maintenance after weight loss, and programs of over a year are currently recommended by the guidelines.[10]
This review will focus on the metabolic parameters (initiators, activators, pathways, and endpoints) achieved consequent to various weight-loss regimens, i.e., dietary modulations, exercise, drug, and surgical intervention aimed at improving metabolic health and long term healthy weight maintenance.
Function
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Function
Metabolism is a group of processes through which food is converted into energy to help maintain bodily function. The energy generated through biochemical pathways is usually in the form of adenosine triphosphate (ATP). A continuous supply of ATP to meet the body's energy demands during activity and rest is fundamental to the metabolic processes that sustain life. During the resting stage, the body requires energy to support activities such as breathing, maintaining blood circulation, brain function, cellular growth and repair, basic hormonal and neurological changes, etc.[11]
The calories needed for maintaining basal (resting phase) metabolism are called basal metabolic rate (BMR). BMR increases with a decrease in body weight to about 0.02 kcal/min, corresponding to each 1% decrease in body weight. Healthy body weight is calculated by the measurement of body mass index (BMI). It assesses the body weight of an individual relative to their height and hence provides a more distinctive account of body fat content than just the weight. Though BMI does not directly measure body fat, it is a useful and inexpensive screening method for clinical and research purposes. For adults, BMI is categorized into four ranges and indicates varying levels of health risks. For Asians, BMI ranges are different.
- BMI below 18.5 indicates underweight
- BMI range of 18.5-24.9 indicates a normal/ healthy state
- BMI range of 25-29.9 indicates overweight
- BMI equal to or higher than 30 is considered obese
Obesity is, however, sub-classified as class-1 obesity (BMI of 30 to < 35), class-2 obesity (BMI of 35 to < 40), and class-3 obesity (BMI of 40 or higher)
- BMI for an individual is calculated by any of the following equations:
- BMI = [weight (kg)/height (m)]
- BMI = [weight (lb)/height (in)] x 703
BMI corresponding to the normal range is associated with health compared to underweight, overweight, or obese ranges. Too little or too much body fat in underweight and overweight/obese reflects a risk of disease predisposition.[12] A healthy metabolism is maintained through normal homeostasis and appropriate regulation of blood pressure, blood glucose, lipid profiles, etc. At the metabolic level, weight loss of 5% of initial weight is associated with improvement in biochemical and physiological parameters of the body and thus health benefits. Furthermore, weight loss programs are directed towards reducing weight by 1 to 2 pounds/week (approximately 0.5 to 1 kg/week).[10] Recommended weight reduction prevents drastic changes in metabolism and is associated with better long-term weight maintenance.[13]
Bodyweight, as estimated by BMI and body fat distribution and composition when assuming a condition of overweight or obesity, impacts metabolic health unfavorably. Notably, some individuals can be metabolically healthy despite being overweight and are categorized as metabolically healthy obese (MHO). MHO indicates the absence of hypertension, dyslipidemia, type 2 diabetes, or insulin resistance and does not present health risks.[14] Contrastingly, individuals categorized as healthy based on BMI values can demonstrate higher metabolic risks and are known as metabolically obese normal weight (MONW).[14] The individual disparity in body weight correlation to health can be challenging, which assumes that less weight is healthy and more unhealthy. Hence, it requires practitioners to carefully assess overall metabolic health and BMI to suggest a weight maintenance regimen to the patients.
Weight management or reduction is considered a standard regimen to overcome high body mass index and reduce predisposition to metabolic, inflammatory, and infectious diseases. Managing bodyweight impinges on modulating the metabolism through diet and calorie restriction, physical activity, intermitted fasting, sleep cycles, etc. Herein, we will discuss the metabolic regulation and consequences of different weight loss regimens.
Calorie Restriction and Dietary Modifications for Weight Loss and Metabolic Consequences
Metabolism constitutes a multitude of biochemical reactions to derive energy from food and drink. The gain of weight usually occurs through metabolic derangement, wherein food intake is more than the energy expenditure from metabolic activities, leading to the accumulation of excess energy in the form of fat deposition in adipose tissues.
Many dietary regimens have been developed to substantiate weight loss as well as maintenance of lost weight. However, none presents to be universally effective. The manifestation of individual differences can be due to lifestyle choices, eating habits, and metabolic variations. According to the American College of Cardiology/American Heart Association Task Force guidelines, a hypocaloric diet (calorie restriction) as a lifestyle intervention method has been proposed to induce a negative energy balance.[15]
Besides efficiently inducing sustained and long-term weight loss, calorie restriction supports metabolic health, prevents diseases, and delays aging.[16] Calorie restriction generates an overall lower metabolic rate and a gradual decline in energy expenditure to match the intake eventually. This helps to generate a metabolic rate to maintain a lower body weight. At the initial phase of calorie restriction, reduction in energy intake is more drastic than energy expenditure, inducing an energy deficit and weight loss. Since energy expenditure (EE) corroborates with body mass, weight loss, in turn, decreases the EE. Over time calorie restriction regimen establishes an energy intake and EE balance, reaching an energy balance with reduced body weight. This decline in EE proportionate to body mass alterations is termed metabolic adaptation. During the calorie restriction regime, the metabolic adaptation during rest (basal metabolism) and activity correlates with weight loss.[17] This is maintained not just through changes in metabolic processes but also compensatory behavioral mechanisms to conserve energy. It is proposed that circulating hormones such as leptin, thyroid hormone, and insulin may mediate calorie restriction responses by influencing heart rate, blood pressure, and sympathetic nervous system.[18] Metabolic adaptation is demonstrated to be specific to the calorie restriction regimen since exercise-induced weight loss does not follow metabolic adaptation.[19]
Calorie restriction-induced slowing down of metabolic rate also limits the mitochondrial generation of reactive oxygen species (ROS). ROS is disruptive to molecular and cellular structures and functions of the body. Diminished ROS production due to the slowing down of metabolism alleviates homeostasis and functional impairments.[20] Thus, calorie restriction-induced weight loss consequently improves metabolic health and reduces oxidative damage at the cellular level, thus enhancing the quality of life and lifespan.[17]
Another challenge faced by overweight and obese individuals is the impairment of metabolic flexibility, where the body cannot switch the use of metabolic substrates depending upon the need, nutrient availability, and environmental cues.[21] Metabolic inflexibility also underpins the development of chronic health issues. Often, weight reduction regimens harness the metabolic flux to be channeled toward the use of fatty acid substrates. Thus, weight loss becomes harder in patients who have developed metabolic inflexibility. During weight loss and maintenance, cellular metabolic processes such as glycolysis and fatty acid oxidation are lowered. Studies have demonstrated that cellular dysregulation of the tricarboxylic acid cycle and substrate switching between glucose and fatty acids play a role in obesity and the development of chronic disease and metabolic syndrome.[22][23] Overweight and obese people demonstrate an overall improvement in metabolic flexibility after weight loss.
Recently, intermittent fasting, also known as time-restricted feeding, has been somewhat effective in weight loss. Intermittent fasting is proposed to affect human circadian rhythms, sleep patterns, lifestyle behaviors, and intestinal microflora.[24][25][26] Feeding regimens that restrict or exclude nighttime eating patterns leading to long fasting intervals may improve metabolic health. These feeding regimens are non-interventional approaches for enhancing the general well-being of the population and are in the interest of public health.
The alternating fasting and feeding cycles stimulate specific biochemical reprogramming directed to utilize stored energy during the fasting periods, termed fasting physiology. It is conjectured that repair mechanisms integral to fasting-refeeding are optimally active during the fasting period. It is thus imperative that periodic and intermittent fasting may trigger factors that help enhance the general health of the individuals. Experimental approaches have demonstrated that combining calorie restriction with intermittent fasting may facilitate fasting physiology to be triggered sooner compared to the regimen of consuming high calories.[27] Also, regulating the food intake timings may induce fasting physiology after feeding cycles on a daily basis. It is thus conducive that periodic and intermittent fasting may trigger factors to enhance general health.
Metabolic Effects of Weight Loss Through Physical Activity and Exercise Training
Moderate to intense physical activities daily effectively maintain body structure and weight after a healthy weight has been achieved. Many weight maintenance regimens follow exercise and resistance training as mainstream mechanisms for controlling unhealthy weight regain. Exercise stimulates a negative energy balance and induces a restructuring of body fat.[28] This subsequently promotes an increase in muscle mass, which can be maintained through regular exercise training besides healthy eating habits, optimal sleep cycles, and relaxation. The biochemical mechanisms modulated through exercise include activation of AMP kinases, uptake of substrates from plasma, beta-oxidation of fats, lipid degradation, and mitochondrial functions. Long-term training eventually leads to increased respiratory and cardiac capacity, better insulin sensing, reduced lipids concentration in plasma and tissues, enhanced oxidative capacity of mitochondria, and overall optimal metabolic functions. However, oxidative stress is induced during physical activity. Though oxidative stress is a detrimental mediator of exercise, it serves as a necessary juncture to facilitate metabolic adaptation through increased mitochondrial function and the anti-oxidative capacity of the body. This phenomenon is called metabolic hormesis.[29]
Skeletal muscle contraction constitutes most substrate channelizing mechanisms during exercise to generate a continual supply of ATP. Since muscle reserves for ATP are small, maintaining the ATP resynthesis rates to match muscle contraction is necessary. Reducing equivalents to support ATP synthesis are obtained from carbohydrates and fat metabolism. This increases the phosphocreatine and glycogen breakdown, thus activating both aerobic and anaerobic respiratory pathways.[30] In addition, the intensity of exercise dictates the amount of ATP needed to fulfill the physical activity demand. Hence, the contribution of aerobic and anaerobic pathways is determined by the duration and intensity of the exercise regime.[31]
Exercise-mediated weight loss and maintenance is considered a prime mechanism in sports physiology to maintain low body fat and retain lean mass, facilitating an optimized body composition.[32] Higher lean body mass composition is advantageous in various sports and improves strength-to-mass ratio, swift mobility, and body structure. However, this requires an overall energy restriction that leads to alterations in hormone concentrations, mitochondrial mechanisms, and EE from a metabolic standpoint. Less body fat and low-calorie intake indicate energy unavailability, substantiating a homeostatic endocrine response towards conserving energy and promoting energy intake.[33] Due to a change in energy metabolism, EE is structured to minimize energy deficits and weight loss, thus promoting weight regain.
Pharmacological and Surgical Intervention For Weight Loss and Metabolic Effects
Although lifestyle changes, dietary modulations, and physical restraint training are the fundamental measures of weight loss, pharmacological and surgical interventions are now becoming common for therapeutic purposes. However, these interventions are limited by their side effects, surgical risks, and efficacy.
Recent advancements in technologies and metabolomics have helped our understanding of the mechanistic pathways and metabolites that are mediators of an increase in BMI and weight gain. However, only five drug therapies have been approved for obesity treatment thus far.[34] These therapies are based on the use of analogs that manipulate gut hormones, facilitating weight loss. Presently, glucagon-like peptide-1 (GLP-1) analogs are used as monotherapy, unimolecular agonists for gastric inhibitory peptide receptor (GIP), GLP-1 receptor, or glucagon receptor are used to induce weight loss. Furthermore, leptin analogs, ghrelin antagonists, amylin mimetics and melanocortin-4 receptor (MC4R), and neuropeptide Y (NPY) antagonists that suppress appetite have demonstrated success in preclinical and clinical trials.[35]
Recently, blood metabolic signatures of adiposity associated with lifestyle factors have been identified. Hence, drug design and repurposing of drugs for weight management have taken a faster pace. The drugs used in the weight loss regime, such as selective inhibitors of pancreatic lipase, stimulators of noradrenaline release leading to the suppression of appetite in combination with drugs to enhance satiety by increasing energy expenditure, thus reducing food intake, have shown an overall success in weight management.[35][36][37][38] However, drug and surgical interventions have shown enhanced benefits for weight management after weight loss when combined with lifestyle changes.
Metabolic Effectors In Weight Management
Metabolic pathways that play a significant role in weight regain, or the maintenance of the lost weight can be divided into intrinsic and extrinsic factors. Extrinsic factors span the lifestyle and psychosocial parameters, while intrinsic factors focus on energy balance and functional resistance to weight loss. Both processes are interconnected through complex metabolic networks. Accordingly, weight loss in individuals with high baseline fat mass progresses to steady maintenance of the lost weight. High fat concentrations lead to loss of fat weight without stress to the adipocytes or reduction of fat-free mass. Continued weight loss management requires effective regimens spanning both intrinsic and extrinsic factors, i.e., limited energy intake, exercise, a fat-free composition of the diet, and proper sleep, besides genetic variability. The final goal is to prevent weight regain by maintaining minimum cellular stress and accumulation of fat. The primary weight gain and weight regain are different metabolic processes. Hence, preventing weight recidivism requires controlling a set of metabolic indices different from those targeted during initial weight loss. Sustaining weight loss underlies diverse homeostatic metabolic adaptations through the modulation of energy expenditure that improves metabolic efficiency. However, it leads to an increase in the signals for energy intake.
Maintaining Energy Balance Through Fat-free Mass and Hormone Regulation
The percentage of body fat lost during calorie restriction negatively correlates with the rate of weight regain, which depends on the baseline BMR. Thus, a higher initial BMR is usually helpful in successful weight maintenance after weight loss.[39] Weight maintenance diets through which fat-free mass is spared are usually less effective in preventing weight regain. Fat-free mass is highly involved in energy expenditure by physical activity. Hence, to increase the possibility of weight maintenance after weight loss, diets rich in protein and low glycemic index are advised together with physical activity. Compared to a low-fat diet, a low glycemic index diet has a more pronounced effect in reducing hunger, minimizing postprandial insulin secretion, and maintaining insulin sensitivity.[40]
Other major regulators of weight maintenance after weight loss are metabolic hormones that modulate the feelings of hunger and satiety, such as leptin, insulin, ghrelin, etc.[41] After a weight-loss period, the reduction in fat mass leads to a decrease in plasma leptin. This drop in the plasma leptin concentration creates a leptin deficiency signal in the brain that subsequently induces a high energy intake response. With 10% body weight loss, a significant deficiency in brain leptin concentration is observed. An experimental observation indicated that injection of leptin in such individuals during the weight maintenance period was associated with a reversal of the deficiency symptoms in the brain areas dedicated to energy intake regulation. Thus, there exists a direct link between leptin and the weight loss process. Leptin concentration changes over time throughout the weight loss regimen and subsequently maintaining a healthy weight. Besides leptin, reduction in the concentration of thyroid hormones, triiodothyronine (T3), and thyroxine (T4) also substantiate weight loss. Notably, thyroid hormones are directly correlated to the leptin concentration throughout weight loss and maintenance.[42]
Similarly, a higher baseline concentration of ghrelin hormone is also associated with improved weight loss. In addition, alteration in plasma ghrelin concentration is related to increased satiety. However, unlike leptin, ghrelin doesn’t seem to have a long-term effect on body weight maintenance. Finally, the hypothalamic-pituitary-thyroid axis seems to be the central modulator for weight maintenance through the influence of leptin as well as other regulatory metabolic hormones.[43]
Other metabolic hormones, namely, peptide YY (PYY), gastric inhibitory peptide, GLP1, amylin, pancreatic polypeptide, and cholecystokinin (CCK), are sporadically shown to regulate hunger and satiety signals. The concentrations of hormones PYY and CCK were shown to reflect initial weight loss levels even after 40% weight gain, thus indicating a negative correlation to weight maintenance after weight loss.[44] A good understanding of these hormones in regulating energy intake can help devise therapeutic or preventive regimens for weight regain.
Physiologic and Cellular Regulation of Weight Maintenance
The plasma concentration of metabolites reflects the physiological activities of tissues and cells. Plasma concentration of some metabolites is observed to vary over time during and after the weight loss and maintenance process, indicating a metabolic adaptation response.[45] The major metabolites that are shown to undergo a time-dependent change effect are free fatty acids, triglycerides, HDL, cholesterol, β-hydroxybutyrate, and glucose. After weight loss, the generation of negative energy balance alters the plasma concentration of metabolites, which is re-established when energy balance takes a new homeostatic position. Hence, the plasma metabolites concentrations may reflect metabolic mechanisms that resist weight modulation. Metabolite concentrations are modulated depending on the amount of weight lost. Research has indicated that a 10% weight loss may lead to the long-term persistence of concentration change in some metabolites. However, the return effect of the plasma concentration of metabolites such as angiotensin I-converting enzyme (ACE), insulin, and leptin to a threshold level is shown to reflect a possible weight regain.[46]
The correlation of plasma leptin, baseline BMI, and initial fat mass with a risk for weight regain points to an active role of the adipocytes. After losing fat, adipocytes experience cellular stress. The cells become smaller in size upon fat loss, affecting the structure-function axis of adipocytes.[47] This is alleviated by adjusting to a new energy balance and renewal of fat and triglyceride storage mechanisms, accompanied by changes in adipokines secretion. The resultant change affirms sufficient fat supply to the adipose tissue. Adipocyte-based energy demands increase high-calorie intake and establish a risk of weight regain.[48]
Adipocytes regulated energy requirement also correlates with a drop in leptin concentrations. Subsequently, many studies have supported that fast initial weight loss results in a more significant amount of lost weight but induces cellular stress and higher reversal. However, a gradual initial weight loss substantiates the metabolic adaptability of adipocytes and a greater prospect for long-term weight maintenance.[48]
Issues of Concern
Weight loss regimens usually depend on dietary modulations and calorie restrictions, exercise, and sometimes drug intervention or surgery. However, it is concerning that most people are unable to maintain the lost weight, and many regain a significant part of the lost weight. Notably, there are individual differences observed in weight maintenance. There is no standard effective regimen developed thus far, and individual differences are observed in the manifestation of such regimens, and in some patients, it may not be successful. These differences in the positive outcome of weight loss management programs may be due to lifestyle choices, eating habits, and individual metabolic variations, besides not complying with a healthy diet.
Weight loss through calorie restrictions poses a risk of bone mobilization or loss. A combination of calorie restriction and exercise does not necessarily prevent or attenuate bone loss. Losing about 5% of body weight raises the risk for fractures, especially in older individuals. It requires a controlled weight-loss program design to pinpoint mechanisms adapted to support the quality and density of bone sites susceptible to bone loss. Hence, besides the clinical regimen of weight loss from the point when it is initiated to achieving a healthy weight, management of lost weight also requires clinical support.
Weight loss through pharmacological and surgical interventions is becoming more appealing. Besides improving an individual's health and emotional status, they effectively reduce the risk factors for metabolic diseases. Nonetheless, they are associated with significant age-specific side effects. Surgical interventions such as sleeve gastrectomy usually lead to swift weight loss but are accompanied by changes in hormones, bone density, and gastrointestinal problems.
Weight regain after weight loss is also a frequent problem encountered in obesity. This tendency is often due to the lack of compliance with exercise or dietary regimens. However, in many cases, it occurs due to physiological mechanisms and not due to high-calorie intake or lack of exercise. Gut hormone secretions may lead to a reduced secretion of anorectic hormones and an enhanced orexigenic hormone affecting metabolic adaptation. This imbalance causes weight to be regained after weight loss has taken place. The BMI-induced metabolic shift may also lead to the weight regain process. Hence, it concerns that many central (metabolic) and peripheral (food craving, hunger sensation, and enjoyment of eating) mechanisms can cause regain of weight.[49][50][51]
Maintaining weight loss after following a specific regimen such as calorie restriction, exercise, drug treatment, or surgical intervention always requires a careful assessment at the individual level. This should be followed by meticulous customization of weight management regimens to achieve a potent, sustained, and healthy body weight.
Clinical Significance
Metabolism plays a major role in the maintenance of a healthy weight after weight loss. Besides calorie restriction, exercise is a significant metabolism booster. Exercise helps build lean muscle mass and increases the metabolic rate to utilize more energy in maintaining it. Many health conditions are related to metabolic derangements. Specific illnesses, such as insulin resistance, thyroid problems, etc., that may affect metabolic function are associated with an inability to maintain a healthy weight. Some medications such as steroids, blood pressure reducers, and antidepressants also induce slowing down of metabolism and hence pose risks of weight gain and regain after a healthy weight loss has been achieved.
From a clinical standpoint, metabolic derangements due to genetic predispositions, lifestyle, behavior, and medication or illness may prevent the maintenance of a healthy weight. Hence, regulation and maintenance of healthy metabolism are imperative to overcome unhealthy weight conditions such as obesity and other associated comorbidities. Notably, as much as 5% weight loss may significantly improve the health of an overweight or obese individual besides reducing the risks for cardiovascular disease, diabetes, impairment in liver and kidney function, etc. Additionally, it leads to an overall reduction of fat and an increase in healthy muscle mass.
Weight loss management is clinically recommended to prevent weight regain and affirm normal blood pressure, healthy triglycerides, and cholesterol levels or reduce the risk for metabolic diseases. Besides a general health index, maintaining a healthy weight has far-reaching benefits. Healthy weight loss reduction causes a general sense of well-being, more energy, reduction in stress levels and better sleep, improved immunity, better mental health, balanced hormones, and an overall enhancement in the quality of social life.
Enhancing Healthcare Team Outcomes
Weight Loss and Metabolic Consequences
Unhealthy weight gain generally occurs through inducing and driving factors that perturb the metabolism, which may vary among individuals. Hence, the practitioners must recognize and evaluate the underlying causes and prescribe a regimen for weight loss directed towards the specific causing and contributing factors to obtain desirable results. Furthermore, weight recidivism is observed at a high rate and thus requires a customized regimen spanning metabolic effectors to maintain lost weight. This will involve a concerted effort from multidisciplinary staff such as physicians, nutritionists, exercise physiologists, and trainers to recognize the potential causes and target their treatment strategies accordingly. Besides, weight reduction and regeneration of healthy metabolism also depend on lifestyle, including healthy behavioral practices and eating habits. Thorough counseling of patients will warrant better patient outcomes. Weight management becomes more complex when it is a therapeutic pathway for health conditions such as type 2 diabetes, cardiovascular diseases, liver or kidney diseases, etc. The outcomes of such therapeutic intervention may depend on a carefully directed approach that prevents adverse side effects. However, to improve therapeutic outcomes, prompt consultation involving an interprofessional group of specialists is recommended.[52][53] [Level 1]
Calorie Restriction
According to the American College of Cardiology/American Heart Association Task Force guidelines, a hypocaloric diet as a lifestyle change has been proposed to induce weight loss and sustained weight management by optimizing energy balance.[15] Calorie restriction is based on reducing average daily caloric intake without malnutrition or lack of essential nutrients. A nutritionist designs a diet regimen in consultation with the physicians to understand the patient's metabolic level and identify comorbidities. This requires the involvement of an interprofessional team that includes physicians, nutritionists, and laboratory technologists. Once the physician and laboratory technologist help diagnose the comorbidity or metabolic causes, nutritionists can help devise an effective calorie restriction regimen for weight management.[54] [Level 1]
Physical Training and Exercise
Routine moderate to intense physical activities are effective in preventing weight regain. For a successful weight maintenance program, well-directed physical training is recommended. However, it depends on personal behavior, dedication, and an effective exercise plan. Initially, this was only considered a domain for physical trainers; however, it is realized that only exercise could not lead to healthy outcomes. Thus it is crucial to obtain assistance from experts from other fields. A complete health profile of the patient through diagnosis by a physician and laboratory technologist can help a physical trainer in devising exercise regimens and resistance/endurance training to generate metabolic activity toward sustained weight maintenance [Level 1]
Drug and Surgical Intervention
Prescribing a medication, especially for weight loss or management, requires careful understanding of the patient's lifestyle, behavior, diagnosis of underlying conditions, and if a person is taking any other drug, etc. Hence, to derive a good outcome, a physician must incorporate assistance from specialists, pharmacists, lab technologists, and nurses to achieve a better outcome from drug therapy when dietary regimens or physical training has not been successful. This also requires complete information about the dietary and exercise regimens to be obtained by the physician. Hence, an interdisciplinary approach is helpful to achieve successful and sustained therapeutic results.
Bariatric or metabolic surgical interventions are a procedure for treating excessive weight gain and for individuals with weight regain. These operations are also carried out to treat diabetes, high blood pressure, sleep apnea, and high cholesterol. These operations modify the stomach and intestines to treat obesity and comorbid conditions. The operation is intended to constrict the stomach size in addition to bypassing a stretch of the intestine. This changes food intake and absorption, resulting in less hunger and a feeling of fullness. Surgical intervention poses a risk factor for the patients; hence, assistance for interdisciplinary teams consisting of surgeons, nurses, and pharmacists is mandatory for assessment, post-operative patient care, monitoring, and follow-up. Furthermore, better outcomes can be enhanced by counseling and informing the patients about the goals and objectives of the bariatric surgery a priori.[55][56] [Level 1]
The surgical procedures used for metabolic surgery are:
- Sleeve gastrectomy
- Gastric bypass
- Adjustable gastric band
- Biliopancreatic diversion with duodenal switch
- Single anastomosis duodeno-ileal bypass with sleeve gastrectomy
These surgical procedures are usually aggressive, so reversal is not easy. Reversal may usually result in complications and risks. After a sleeve gastrectomy, the procedure can never be reversed.
Evidence-based Approach
Excessive and unhealthy weight gain generally progresses through inducing and driving factors that perturb the metabolism and vary among individuals. Long-term management of overweight conditions and maintenance of lost weight requires ongoing clinical attention. A weight management regimen follows a sequential metabolic adaptation toward establishing sustained homeostasis. An interprofessional staff involving physicians, surgeons, nurses, pharmacists, nutritionists, exercise physiologists, and trainers who can determine the underlying causes and devise regimens can provide a holistic and integrated approach to weight maintenance.[57][58][51] This will facilitate the best possible outcomes. The basic indices that define metabolic derangements as key culprits for weight regain must be evaluated before determining a therapeutic regime. Hence, the essential role of diagnostic laboratory professionals cannot be undermined.[59]
A collaborative effort in decision-making and patient counseling are key elements for a good outcome in weight management to prevent recidivism. The interprofessional care of the patient must follow integrated care management combined with an evidence-based method for planning and evaluating all activities. A thorough understanding of signs and symptoms can lead to implementing a more successful regimen and better outcomes.[60] [Level 3]
References
Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nature reviews. Endocrinology. 2021 Mar:17(3):135-149. doi: 10.1038/s41574-020-00462-1. Epub 2021 Jan 21 [PubMed PMID: 33479538]
Brown JC, Carson TL, Thompson HJ, Agurs-Collins T. The Triple Health Threat of Diabetes, Obesity, and Cancer-Epidemiology, Disparities, Mechanisms, and Interventions. Obesity (Silver Spring, Md.). 2021 Jun:29(6):954-959. doi: 10.1002/oby.23161. Epub [PubMed PMID: 34029445]
Kaw R, Wong J, Mokhlesi B. Obesity and Obesity Hypoventilation, Sleep Hypoventilation, and Postoperative Respiratory Failure. Anesthesia and analgesia. 2021 May 1:132(5):1265-1273. doi: 10.1213/ANE.0000000000005352. Epub [PubMed PMID: 33857968]
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP, American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 May 25:143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22 [PubMed PMID: 33882682]
Yim HE, Yoo KH. Obesity and chronic kidney disease: prevalence, mechanism, and management. Clinical and experimental pediatrics. 2021 Oct:64(10):511-518. doi: 10.3345/cep.2021.00108. Epub 2021 Apr 6 [PubMed PMID: 33831296]
Zhang P, Atkinson KM, Bray GA, Chen H, Clark JM, Coday M, Dutton GR, Egan C, Espeland MA, Evans M, Foreyt JP, Greenway FL, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Huckfeldt PJ, Jackson SD, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Knowler WC, Korytkowski M, Lewis CE, Maruthur NM, Michaels S, Montez MG, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Rushing JT, Steinburg H, Wadden TA, Wing RR, Wyatt H, Yanovski SZ, Look AHEAD Research Group. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. Diabetes care. 2021 Jan:44(1):67-74. doi: 10.2337/dc20-0358. Epub 2020 Nov 9 [PubMed PMID: 33168654]
Wang J, Sato T, Sakuraba A. Coronavirus Disease 2019 (COVID-19) Meets Obesity: Strong Association between the Global Overweight Population and COVID-19 Mortality. The Journal of nutrition. 2021 Jan 4:151(1):9-10. doi: 10.1093/jn/nxaa375. Epub [PubMed PMID: 33188432]
Kuk JL, Christensen RAG, Wharton S. Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health. Journal of obesity. 2019:2019():3609642. doi: 10.1155/2019/3609642. Epub 2019 Jan 29 [PubMed PMID: 30838133]
Keenan GS, Christiansen P, Hardman CA. Household Food Insecurity, Diet Quality, and Obesity: An Explanatory Model. Obesity (Silver Spring, Md.). 2021 Jan:29(1):143-149. doi: 10.1002/oby.23033. Epub 2020 Nov 1 [PubMed PMID: 33135388]
Level 2 (mid-level) evidenceAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. Obesity (Silver Spring, Md.). 2014 Jul:22 Suppl 2():S5-39. doi: 10.1002/oby.20821. Epub [PubMed PMID: 24961825]
Level 1 (high-level) evidenceBawden SJ, Stephenson MC, Ciampi E, Hunter K, Marciani L, Macdonald IA, Aithal GP, Morris PG, Gowland PA. Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: A (31)P MRS study. Clinical nutrition (Edinburgh, Scotland). 2016 Jun:35(3):645-9. doi: 10.1016/j.clnu.2015.04.001. Epub 2015 Apr 14 [PubMed PMID: 25935852]
Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ (Clinical research ed.). 2016 May 4:353():i2156. doi: 10.1136/bmj.i2156. Epub 2016 May 4 [PubMed PMID: 27146380]
Level 1 (high-level) evidenceAstrup A, Rössner S. Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2000 May:1(1):17-9 [PubMed PMID: 12119640]
Stefan N. Metabolically Healthy and Unhealthy Normal Weight and Obesity. Endocrinology and metabolism (Seoul, Korea). 2020 Sep:35(3):487-493. doi: 10.3803/EnM.2020.301. Epub 2020 Aug 20 [PubMed PMID: 32814419]
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24:129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12 [PubMed PMID: 24222017]
Level 1 (high-level) evidenceFlanagan EW, Most J, Mey JT, Redman LM. Calorie Restriction and Aging in Humans. Annual review of nutrition. 2020 Sep 23:40():105-133. doi: 10.1146/annurev-nutr-122319-034601. Epub 2020 Jun 19 [PubMed PMID: 32559388]
Most J, Redman LM. Impact of calorie restriction on energy metabolism in humans. Experimental gerontology. 2020 May:133():110875. doi: 10.1016/j.exger.2020.110875. Epub 2020 Feb 11 [PubMed PMID: 32057825]
Müller MJ, Enderle J, Pourhassan M, Braun W, Eggeling B, Lagerpusch M, Glüer CC, Kehayias JJ, Kiosz D, Bosy-Westphal A. Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited. The American journal of clinical nutrition. 2015 Oct:102(4):807-19. doi: 10.3945/ajcn.115.109173. Epub 2015 Sep 23 [PubMed PMID: 26399868]
Edinburgh RM,Koumanov F,Gonzalez JT, Impact of pre-exercise feeding status on metabolic adaptations to endurance-type exercise training. The Journal of physiology. 2021 Jan 11; [PubMed PMID: 33428210]
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013 Jun 6:153(6):1194-217. doi: 10.1016/j.cell.2013.05.039. Epub [PubMed PMID: 23746838]
Level 3 (low-level) evidenceHue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. American journal of physiology. Endocrinology and metabolism. 2009 Sep:297(3):E578-91. doi: 10.1152/ajpendo.00093.2009. Epub 2009 Jun 16 [PubMed PMID: 19531645]
Level 3 (low-level) evidenceTareen SHK, Kutmon M, Adriaens ME, Mariman ECM, de Kok TM, Arts ICW, Evelo CT. Exploring the cellular network of metabolic flexibility in the adipose tissue. Genes & nutrition. 2018:13():17. doi: 10.1186/s12263-018-0609-3. Epub 2018 Jul 5 [PubMed PMID: 30002738]
Tareen SHK, Adriaens ME, Arts ICW, de Kok TM, Vink RG, Roumans NJT, van Baak MA, Mariman ECM, Evelo CT, Kutmon M. Profiling Cellular Processes in Adipose Tissue during Weight Loss Using Time Series Gene Expression. Genes. 2018 Oct 29:9(11):. doi: 10.3390/genes9110525. Epub 2018 Oct 29 [PubMed PMID: 30380678]
Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell metabolism. 2016 Jun 14:23(6):1048-1059. doi: 10.1016/j.cmet.2016.06.001. Epub [PubMed PMID: 27304506]
Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annual review of nutrition. 2017 Aug 21:37():371-393. doi: 10.1146/annurev-nutr-071816-064634. Epub 2017 Jul 17 [PubMed PMID: 28715993]
Frank J, Gupta A, Osadchiy V, Mayer EA. Brain-Gut-Microbiome Interactions and Intermittent Fasting in Obesity. Nutrients. 2021 Feb 10:13(2):. doi: 10.3390/nu13020584. Epub 2021 Feb 10 [PubMed PMID: 33578763]
Longo VD,Mattson MP, Fasting: molecular mechanisms and clinical applications. Cell metabolism. 2014 Feb 4; [PubMed PMID: 24440038]
Level 3 (low-level) evidenceRoss R, Soni S, Houle SA. Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. Nutrients. 2020 Mar 25:12(4):. doi: 10.3390/nu12040891. Epub 2020 Mar 25 [PubMed PMID: 32218121]
Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Experimental gerontology. 2010 Jun:45(6):410-8. doi: 10.1016/j.exger.2010.03.014. Epub 2010 Mar 27 [PubMed PMID: 20350594]
Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014 Nov 6:159(4):738-49. doi: 10.1016/j.cell.2014.10.029. Epub [PubMed PMID: 25417152]
Level 3 (low-level) evidenceHargreaves M, Spriet LL. Skeletal muscle energy metabolism during exercise. Nature metabolism. 2020 Sep:2(9):817-828. doi: 10.1038/s42255-020-0251-4. Epub 2020 Aug 3 [PubMed PMID: 32747792]
Trexler ET, Smith-Ryan AE, Norton LE. Metabolic adaptation to weight loss: implications for the athlete. Journal of the International Society of Sports Nutrition. 2014 Feb 27:11(1):7. doi: 10.1186/1550-2783-11-7. Epub 2014 Feb 27 [PubMed PMID: 24571926]
Koliaki C,Liatis S,Dalamaga M,Kokkinos A, The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity. Current obesity reports. 2020 Sep; [PubMed PMID: 32647952]
Williams DM, Nawaz A, Evans M. Drug Therapy in Obesity: A Review of Current and Emerging Treatments. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2020 Jun:11(6):1199-1216. doi: 10.1007/s13300-020-00816-y. Epub 2020 Apr 15 [PubMed PMID: 32297119]
Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD, Endocrine Society. Pharmacological management of obesity: an endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2015 Feb:100(2):342-62. doi: 10.1210/jc.2014-3415. Epub 2015 Jan 15 [PubMed PMID: 25590212]
Level 1 (high-level) evidenceKhedr NF, Ebeid AM, Khalil RM. New insights into weight management by orlistat in comparison with cinnamon as a natural lipase inhibitor. Endocrine. 2020 Jan:67(1):109-116. doi: 10.1007/s12020-019-02127-0. Epub 2019 Nov 13 [PubMed PMID: 31721089]
Sherman MM, Ungureanu S, Rey JA. Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults. P & T : a peer-reviewed journal for formulary management. 2016 Mar:41(3):164-72 [PubMed PMID: 26957883]
Van Gaal L, Dirinck E. Pharmacological Approaches in the Treatment and Maintenance of Weight Loss. Diabetes care. 2016 Aug:39 Suppl 2():S260-7. doi: 10.2337/dcS15-3016. Epub [PubMed PMID: 27440841]
Chopra S,Malhotra A,Ranjan P,Vikram NK,Sarkar S,Siddhu A,Kumari A,Kaloiya GS,Kumar A, Predictors of successful weight loss outcomes amongst individuals with obesity undergoing lifestyle interventions: A systematic review. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2021 Mar [PubMed PMID: 33200547]
Level 1 (high-level) evidencede Carvalho KMB, Pizato N, Botelho PB, Dutra ES, Gonçalves VSS. Dietary protein and appetite sensations in individuals with overweight and obesity: a systematic review. European journal of nutrition. 2020 Sep:59(6):2317-2332. doi: 10.1007/s00394-020-02321-1. Epub 2020 Jul 10 [PubMed PMID: 32648023]
Level 1 (high-level) evidenceThom G, Dombrowski SU, Brosnahan N, Algindan YY, Rosario Lopez-Gonzalez M, Roditi G, Lean MEJ, Malkova D. The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study. European journal of clinical nutrition. 2020 Apr:74(4):622-632. doi: 10.1038/s41430-020-0568-9. Epub 2020 Feb 4 [PubMed PMID: 32020057]
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J. Long-term persistence of hormonal adaptations to weight loss. The New England journal of medicine. 2011 Oct 27:365(17):1597-604. doi: 10.1056/NEJMoa1105816. Epub [PubMed PMID: 22029981]
Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. The Journal of clinical investigation. 2008 Jul:118(7):2583-91. doi: 10.1172/JCI35055. Epub [PubMed PMID: 18568078]
Level 1 (high-level) evidenceDeBenedictis JN, Nymo S, Ollestad KH, Boyesen GA, Rehfeld JF, Holst JJ, Truby H, Kulseng B, Martins C. Changes in the Homeostatic Appetite System After Weight Loss Reflect a Normalization Toward a Lower Body Weight. The Journal of clinical endocrinology and metabolism. 2020 Jul 1:105(7):e2538-46. doi: 10.1210/clinem/dgaa202. Epub [PubMed PMID: 32301981]
Geidenstam N, Al-Majdoub M, Ekman M, Spégel P, Ridderstråle M. Metabolite profiling of obese individuals before and after a one year weight loss program. International journal of obesity (2005). 2017 Sep:41(9):1369-1378. doi: 10.1038/ijo.2017.124. Epub 2017 May 22 [PubMed PMID: 28529327]
Lu SC, Akanji AO. Leptin, Obesity, and Hypertension: A Review of Pathogenetic Mechanisms. Metabolic syndrome and related disorders. 2020 Nov:18(9):399-405. doi: 10.1089/met.2020.0065. Epub 2020 Sep 1 [PubMed PMID: 32876506]
van Baak MA, Mariman ECM. Mechanisms of weight regain after weight loss - the role of adipose tissue. Nature reviews. Endocrinology. 2019 May:15(5):274-287. doi: 10.1038/s41574-018-0148-4. Epub [PubMed PMID: 30655624]
Mai K, Li L, Wiegand S, Brachs M, Leupelt V, Ernert A, Kühnen P, Hübner N, Robinson P, Chen W, Krude H, Spranger J. An Integrated Understanding of the Molecular Mechanisms of How Adipose Tissue Metabolism Affects Long-term Body Weight Maintenance. Diabetes. 2019 Jan:68(1):57-65. doi: 10.2337/db18-0440. Epub 2018 Nov 2 [PubMed PMID: 30389745]
Level 3 (low-level) evidenceDavidson TL, Jones S, Roy M, Stevenson RJ. The Cognitive Control of Eating and Body Weight: It's More Than What You "Think". Frontiers in psychology. 2019:10():62. doi: 10.3389/fpsyg.2019.00062. Epub 2019 Feb 13 [PubMed PMID: 30814963]
Greenway FL, Physiological adaptations to weight loss and factors favouring weight regain. International journal of obesity (2005). 2015 Aug [PubMed PMID: 25896063]
Roberts CA, Christiansen P, Halford JCG. Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data? Acta diabetologica. 2017 Aug:54(8):715-725. doi: 10.1007/s00592-017-0994-x. Epub 2017 Apr 19 [PubMed PMID: 28421338]
Chao AM, Wadden TA, Walsh OA, Gruber KA, Alamuddin N, Berkowitz RI, Tronieri JS. Changes in health-related quality of life with intensive behavioural therapy combined with liraglutide 3.0 mg per day. Clinical obesity. 2019 Dec:9(6):e12340. doi: 10.1111/cob.12340. Epub 2019 Nov 5 [PubMed PMID: 31691531]
Level 2 (mid-level) evidenceKelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S, NN8022-4180 Trial Investigators. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. 2020 May 28:382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31 [PubMed PMID: 32233338]
Level 1 (high-level) evidenceStewart TM, Bhapkar M, Das S, Galan K, Martin CK, McAdams L, Pieper C, Redman L, Roberts S, Stein RI, Rochon J, Williamson DA, CALERIE Study Group. Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 (CALERIE Phase 2) screening and recruitment: methods and results. Contemporary clinical trials. 2013 Jan:34(1):10-20. doi: 10.1016/j.cct.2012.08.011. Epub 2012 Sep 5 [PubMed PMID: 22981898]
Level 1 (high-level) evidenceChang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA surgery. 2014 Mar:149(3):275-87. doi: 10.1001/jamasurg.2013.3654. Epub [PubMed PMID: 24352617]
Level 1 (high-level) evidenceMarshall S, Mackay H, Matthews C, Maimone IR, Isenring E. Does intensive multidisciplinary intervention for adults who elect bariatric surgery improve post-operative weight loss, co-morbidities, and quality of life? A systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2020 Jul:21(7):e13012. doi: 10.1111/obr.13012. Epub 2020 Mar 20 [PubMed PMID: 32196906]
Level 2 (mid-level) evidenceStubbs RJ, Duarte C, Palmeira AL, Sniehotta FF, Horgan G, Larsen SC, Marques MM, Evans EH, Ermes M, Harjumaa M, Turicchi J, O'Driscoll R, Scott SE, Pearson B, Ramsey L, Mattila E, Matos M, Sacher P, Woodward E, Mikkelsen ML, Sainsbury K, Santos I, Encantado J, Stalker C, Teixeira PJ, Heitmann BL. Evidence-Based Digital Tools for Weight Loss Maintenance: The NoHoW Project. Obesity facts. 2021:14(3):320-333. doi: 10.1159/000515663. Epub 2021 Apr 29 [PubMed PMID: 33915534]
Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard KE, Maki KC. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. Journal of clinical lipidology. 2019 Sep-Oct:13(5):689-711.e1. doi: 10.1016/j.jacl.2019.08.003. Epub 2019 Sep 13 [PubMed PMID: 31611148]
Wedell-Neergaard AS, Krogh-Madsen R, Petersen GL, Hansen ÅM, Pedersen BK, Lund R, Bruunsgaard H. Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity. PloS one. 2018:13(3):e0194991. doi: 10.1371/journal.pone.0194991. Epub 2018 Mar 28 [PubMed PMID: 29590212]
Torti J, Luig T, Borowitz M, Johnson JA, Sharma AM, Campbell-Scherer DL. The 5As team patient study: patient perspectives on the role of primary care in obesity management. BMC family practice. 2017 Feb 8:18(1):19. doi: 10.1186/s12875-017-0596-2. Epub 2017 Feb 8 [PubMed PMID: 28178930]
Level 3 (low-level) evidence